A Simple Score (MOG-AR) to Identify Individuals at High Risk of Relapse After MOGAD Attack

Yun Xu1, Huaxing Meng1, Moli Fan1

  • 1From the Department of Neurology (Y.X., L.Y., J.S., Y.Y., Y.W., H.C., H.W., T.S., F.-D.S., X.Z., D.-C.T.), China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University; Department of Neurology (H.M.), First Hospital of Shanxi Medical University, Taiyuan; Department of Neurology (M.F., C.-S.Y., F.-D.S.), Tianjin Neurological Institute, Tianjin Medical University General Hospital; and Department of Neurology (J.F.), The First Affiliated Hospital of Chongqing Medical University, China.

Abstract

Insights

Predicting relapse in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is possible. A new MOG-AR score identifies patients at higher risk for MOGAD relapse, aiding treatment decisions.

Area of Science:

  • Neuroimmunology
  • Neurology
  • Clinical Prediction Models

Background:

  • Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune disorder affecting the central nervous system.
  • Predicting relapse is crucial for managing MOGAD and optimizing patient outcomes.
  • Identifying reliable predictors of relapse can guide therapeutic strategies and monitoring protocols.

Purpose of the Study:

  • To identify predictors of relapse in patients diagnosed with MOGAD.
  • To develop and validate a simple risk score for predicting MOGAD relapse.
  • To inform clinical management and personalize treatment approaches for MOGAD patients.

Main Methods:

  • Prospective cohort study of 188 MOGAD patients from the China National Registry of Neuro-Inflammatory Diseases (CNRID).
  • Patients were randomly assigned to model development (75%) and internal validation (25%) cohorts.
  • Andersen-Gill models were used to construct and validate prediction models, generating a nomogram and relapse risk score (MOG-AR).

Main Results:

  • Key predictors for MOGAD relapse included female sex, age 45 years or older, immunosuppressive therapy, prolonged oral corticosteroid use (>3 months), and onset phenotype.
  • The developed MOG-AR score, incorporating these factors, demonstrated strong predictive ability for MOGAD relapse.
  • A MOG-AR score of 13-16 indicated a significantly higher risk of relapse (HR: 3.285).

Conclusions:

  • MOGAD relapse risk is predictable using clinical and treatment-related factors.
  • The MOG-AR score shows promise for identifying patients at high risk of relapse.
  • Further external validation of the MOG-AR score is warranted to guide treatment and monitoring frequency.

Related Concept Videos

Multiple Comparison Tests01:13

Multiple Comparison Tests

Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
Methods of Documentation II: POMR01:26

Methods of Documentation II: POMR

The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Design Example: Analyzing Capacity Contours for Flood Risk Assessment01:17

Design Example: Analyzing Capacity Contours for Flood Risk Assessment

Flood risk assessment involves careful planning and analysis to ensure the safety of communities near water retention structures. Capacity contours are a vital tool in this process, as they illustrate the potential spread of water at specific levels in a given area. In the context of building a bund across a small valley, these contours play a critical role in evaluating the safety of nearby residential areas.In this example, the bund is intended to store stormwater in the valley. The engineers...
Hazard Rate01:11

Hazard Rate

The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...